|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cooper JS, Porter K, Mallin K, Hoffman HT,
Weber RS, Ang KK, Gay EG and Langer CJ: National Cancer Database
report on cancer of the head and neck: 10-year update. Head Neck.
31:748–758. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Day D, Hansen AR and Siu LL:
Hypopharyngeal cancer: looking back, moving forward. Curr Oncol.
23:221–222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hall SF, Groome PA, Irish J and O'Sullivan
B: The natural history of patients with squamous cell carcinoma of
the hypopharynx. Laryngoscope. 118:1362–1371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martinez-Outschoorn UE, Peiris-Pages M,
Pestell RG, Sotgia F and Lisanti MP: Cancer metabolism: A
therapeutic perspective. Nat Rev Clin Oncol. 14:11–31. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wierstra I: The transcription factor FOXM1
(Forkhead box M1): Proliferation-specific expression, transcription
factor function, target genes, mouse models, and normal biological
roles. Adv Cancer Res. 118:97–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petrovic V: FoxM1 regulates cell cycle
progression through multiple mechanisms. University of Illinois at
Chicago; Dissertations & Theses - Gradworks. 2008
|
|
9
|
Halasi M and Gartel AL: FOX(M1) news: it
is cancer. Mol Cancer Ther. 12:245–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miao L, Xiong X, Lin Y, Cheng Y, Lu J,
Zhang J and Cheng N: Down-regulation of FoxM1 leads to the
inhibition of the epithelial-mesenchymal transition in gastric
cancer cells. Cancer Genet. 207:75–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong FF, Qu ZQ, Yuan HH, Wang JY, Zhao M,
Guo YH, Shi J, Gong XD, Zhu YL, Liu F, et al: Overexpression of
FOXM1 is associated with EMT and is a predictor of poor prognosis
in non-small cell lung cancer. Oncol Rep. 31:2660–2668. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang L, Wang P and Chen H: Overexpression
of FOXM1 is associated with metastases of nasopharyngeal carcinoma.
Ups J Med Sci. 119:324–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun HC, Li M, Lu JL, Yan DW, Zhou CZ, Fan
JW, Qin XB, Tang HM and Peng ZH: Overexpression of Forkhead box M1
protein associates with aggressive tumor features and poor
prognosis of hepatocellular carcinoma. Oncol Rep. 25:1533–1539.
2011.PubMed/NCBI
|
|
14
|
Wu XR, Chen YH, Liu DM, Sha JJ, Xuan HQ,
Bo JJ and Huang YR: Increased expression of forkhead box M1 protein
is associated with poor prognosis in clear cell renal cell
carcinoma. Med Oncol. 30:3462013. View Article : Google Scholar
|
|
15
|
Xia JT, Wang H, Liang LJ, Peng BG, Wu ZF,
Chen LZ, Xue L, Li Z and Li W: Overexpression of FOXM1 is
associated with poor prognosis and clinicopathologic stage of
pancreatic ductal adenocarcinoma. Pancreas. 41:629–635. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahmad A, Wang Z, Kong D, Ali S, Li Y,
Banerjee S, Ali R and Sarkar FH: FoxM1 down-regulation leads to
inhibition of proliferation, migration and invasion of breast
cancer cells through the modulation of extra-cellular matrix
degrading factors. Breast Cancer Res Treat. 122:337–346. 2010.
View Article : Google Scholar
|
|
17
|
Nakamura S, Hirano I, Okinaka K, Takemura
T, Yokota D, Ono T, Shigeno K, Shibata K, Fujisawa S and Ohnishi K:
The FOXM1 transcriptional factor promotes the proliferation of
leukemia cells through modulation of cell cycle progression in
acute myeloid leukemia. Carcinogenesis. 31:2012–2021. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang L, Wu X, Wang P, Wen T, Yu C, Wei L
and Chen H: Targeting FoxM1 by thiostrepton inhibits growth and
induces apoptosis of laryngeal squamous cell carcinoma. J Cancer
Res Clin Oncol. 141:971–981. 2015. View Article : Google Scholar
|
|
19
|
Huang C, Qiu Z, Wang L, Peng Z, Jia Z,
Logsdon CD, Le X, Wei D, Huang S and Xie K: A novel FoxM1-caveolin
signaling pathway promotes pancreatic cancer invasion and
metastasis. Cancer Res. 72:655–665. 2012. View Article : Google Scholar :
|
|
20
|
Xue J, Lin X, Chiu WT, Chen YH, Yu G, Liu
M, Feng XH, Sawaya R, Medema RH, Hung MC and Huang S: Sustained
activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer
metastasis. J Clin Invest. 124:564–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ghanim B, Klikovits T, Hoda MA, Lang G,
Szirtes I, Setinek U, Rozsas A, Renyi-Vamos F, Laszlo V, Grusch M,
et al: Ki67 index is an independent prognostic factor in
epithelioid but not in non-epithelioid malignant pleural
mesothelioma: A multicenter study. Br J Cancer. 112:783–792. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mego M, Reuben J and Mani S:
Epithelial-mesenchymal transition (EMT) and cancer stem cells
(CSCs): The Traveling Metastasis. Liquid Biopsies in Solid Tumors.
Cancer Drug Discovery and Development. Cristofanilli M: Humana
Press; Totowa, NJ: pp. 67–80. 2017, View Article : Google Scholar
|
|
23
|
Chen T, You Y, Jiang H and Wang ZZ:
Epithelial-mesenchymal transition (EMT): A biological process in
the development, stem cell differentiation, and tumorigenesis. J
Cell Physiol. Jan 12–2017, (Epub ahead of print). https://doi.org/10.1002/jcp.25797.
View Article : Google Scholar
|
|
24
|
Chodniewicz D and Klemke RL: Guiding cell
migration through directed extension and stabilization of
pseudopodia. Exp Cell Res. 301:31–37. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mochizuki M, Tamai K, Imai T, Sugawara S,
Ogama N, Nakamura M, Matsuura K, Yamaguchi K, Satoh K, Sato I, et
al: CD271 regulates the proliferation and motility of
hypopharyngeal cancer cells. Sci Rep. 6:307072016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang L, Chen C, Zhang G, Ju Y, Zhang J,
Wang H and Li J: STK33 overexpression in hypopharyngeal squamous
cell carcinoma: Possible role in tumorigenesis. BMC Cancer.
15:132015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen C, Huang L, Zhang G, Li Y, Li L, Bai
X, Liu W, Wang H and Li J: STK33 potentiates the malignancy of
hypopharyngeal squamous carcinoma: Possible relation to calcium.
Cancer Biol Ther. 17:976–984. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wierstra I: FOXM1 (Forkhead box M1) in
tumorigenesis: Overexpression in human cancer, implication in
tumorigenesis, oncogenic functions, tumor-suppressive properties,
and target of anticancer therapy. Adv Cancer Res. 119:191–419.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ahn H, Sim J, Abdul R, Chung MS, Paik SS,
Oh YH, Park CK and Jang K: Increased expression of forkhead box M1
is associated with aggressive phenotype and poor prognosis in
estrogen receptor-positive breast cancer. J Korean Med Sci.
30:390–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ito T, Kohashi K, Yamada Y, Iwasaki T,
Maekawa A, Kuda M, Hoshina D, Abe R, Furue M and Oda Y: Prognostic
significance of forkhead Box M1 (FOXM1) expression and antitumor
effect of FOXM1 inhibition in angiosarcoma. J Cancer. 7:823–830.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wierstra I and Alves J: FOXM1, a typical
proliferation-associated transcription factor. Biol Chem.
388:1257–1274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen H, Yang C, Yu L, Xie L, Hu J, Zeng L
and Tan Y: Adenovirus-mediated RNA interference targeting FOXM1
transcription factor suppresses cell proliferation and tumor growth
of nasopharyngeal carcinoma. J Gene Med. 14:231–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang C, Chen H, Yu L, Shan L, Xie L, Hu J,
Chen T and Tan Y: Inhibition of FOXM1 transcription factor
suppresses cell proliferation and tumor growth of breast cancer.
Cancer Gene Ther. 20:117–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xue Y, Zhang G, Xu R, Zou X, Zhong X, Wu
G, Wang X, Long D, Wu Y, Xu H, et al: Overexpression of FoxM1 is
associated with tumor progression. J Urol. 189:e7832013. View Article : Google Scholar
|
|
35
|
Bhat UG, Halasi M and Gartel AL: Thiazole
antibiotics target FoxM1 and induce apoptosis in human cancer
cells. PLoS One. 4:e5592. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park HJ, Gusarova G, Wang Z, Carr JR, Li
J, Kim KH, Qiu J, Park YD, Williamson PR, Hay N, et al:
Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med.
3:21–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang C, Wang Y, Feng Y, Zhang Y, Ji B,
Wang S and Sun Y, Zhu C, Zhang D and Sun Y: Gli1 promotes
colorectal cancer metastasis in a Foxm1-dependent manner by
activating EMT and PI3K-AKT signaling. Oncotarget. 7:86134–86147.
2016.PubMed/NCBI
|
|
38
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen B, Zeng X, He Y, Wang X, Liang Z, Liu
J, Zhang P, Zhu H, Xu N and Liang S: STC2 promotes the
epithelial-mesenchymal transition of colorectal cancer cells
through AKT-ERK signaling pathways. Oncotarget. 7:71400–71416.
2016.PubMed/NCBI
|
|
40
|
Xiang J, Fu X, Ran W and Wang Z: Grhl2
reduces invasion and migration through inhibition of TGFβ-induced
EMT in gastric cancer. Oncogenesis. 6:e2842017. View Article : Google Scholar
|
|
41
|
Ganguly A and Cabral F: The arresting
action of microtubules in cell motility. Cell Cycle. 10:2614–2615.
2011. View Article : Google Scholar : PubMed/NCBI
|
